APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetic Screening for Carrier Diseases

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Genetic Screening for Carrier Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

1 January 2026191 pages

Choose your research edition.

Industry ResearchGenetic Screening for Carrier Diseases Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetic Screening for Carrier Diseases Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Genetic Screening for Carrier Diseases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetic Screening for Carrier Diseases Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetic Screening for Carrier Diseases Market Analysis and Forecast 2026-2032213 pages · $4,950 USD

Market perspective

The global Genetic Screening for Carrier Diseases market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Genetic Screening for Carrier Diseases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genetic Screening for Carrier Diseases include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Invitae, MedGenome, Myriad Genetics, Roche, Natera and OPKO Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Genetic Screening for Carrier Diseases market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Genetic Screening for Carrier Diseases and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Genetic Screening for Carrier Diseases revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Genetic Screening for Carrier Diseases market size, projected growth trends, production technologies, key applications, and end-use industries.

Genetic Screening for Carrier Diseases Segment by Company

Thermo Fisher Scientific

Eurofins Scientific

Illumina

Invitae

MedGenome

Myriad Genetics

Roche

Natera

OPKO Health

23andMe

bioMérieux

EKF Diagnostics

Gene by Gene (myDNA)

Fulgent Genetics

NxGen MDx

Sonic Genetics

My Baby

AncestryDNA

DiaSorin

Grifols

BGI Genomics

Chigene

Jiajian Medical Testing

Genesky

Berry Genomics

Weihansi Biomedical Technology

Annaroad

Genetic Screening for Carrier Diseases Segment by Type

NGS

Whole Exome Sequencing

Others

Genetic Screening for Carrier Diseases Segment by Application

Couple

Individual

Genetic Screening for Carrier Diseases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetic Screening for Carrier Diseases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetic Screening for Carrier Diseases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetic Screening for Carrier Diseases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Genetic Screening for Carrier Diseases in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Genetic Screening for Carrier Diseases industry.

Chapter 3: Detailed analysis of Genetic Screening for Carrier Diseases companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetic Screening for Carrier Diseasesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genetic Screening for Carrier Diseases Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of NGS Table 3. Key Players of Whole Exome Sequencing Table 4. Key Players of Others Table 4. Global Genetic Screening for Carrier Diseases Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Couple Table 6. Key Players of Individual Table 7. Global Genetic Screening for Carrier Diseases Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Genetic Screening for Carrier Diseases Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Genetic Screening for Carrier Diseases Market Share by Region (2021-2026) Table 10. Global Genetic Screening for Carrier Diseases Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Genetic Screening for Carrier Diseases Market Share by Region (2027-2032) Table 12. Genetic Screening for Carrier Diseases Industry Trends Table 13. Genetic Screening for Carrier Diseases Industry Drivers Table 14. Genetic Screening for Carrier Diseases Industry Opportunities and Challenges Table 15. Genetic Screening for Carrier Diseases Industry Restraints Table 16. Global Genetic Screening for Carrier Diseases Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Genetic Screening for Carrier Diseases Revenue Market Share by Company (2021-2026) Table 18. Global Genetic Screening for Carrier Diseases Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Genetic Screening for Carrier Diseases Key Company Head Office and Area Served Table 20. Global Genetic Screening for Carrier Diseases Company, Product Type & Application Table 21. Global Genetic Screening for Carrier Diseases Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Genetic Screening for Carrier Diseases by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Genetic Screening for Carrier Diseases Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Genetic Screening for Carrier Diseases Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Genetic Screening for Carrier Diseases Revenue Market Share by Type (2021-2026) Table 28. Global Genetic Screening for Carrier Diseases Revenue Market Share by Type (2027-2032) Table 29. Global Genetic Screening for Carrier Diseases Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Genetic Screening for Carrier Diseases Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Genetic Screening for Carrier Diseases Revenue Market Share by Application (2021-2026) Table 33. Global Genetic Screening for Carrier Diseases Revenue Market Share by Application (2027-2032) Table 34. Thermo Fisher Scientific Company Information Table 35. Thermo Fisher Scientific Business Overview Table 36. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Portfolio Table 38. Thermo Fisher Scientific Recent Development Table 39. Eurofins Scientific Company Information Table 40. Eurofins Scientific Business Overview Table 41. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Eurofins Scientific Genetic Screening for Carrier Diseases Product Portfolio Table 43. Eurofins Scientific Recent Development Table 44. Illumina Company Information Table 45. Illumina Business Overview Table 46. Illumina Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Illumina Genetic Screening for Carrier Diseases Product Portfolio Table 48. Illumina Recent Development Table 49. Invitae Company Information Table 50. Invitae Business Overview Table 51. Invitae Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Invitae Genetic Screening for Carrier Diseases Product Portfolio Table 53. Invitae Recent Development Table 54. MedGenome Company Information Table 55. MedGenome Business Overview Table 56. MedGenome Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. MedGenome Genetic Screening for Carrier Diseases Product Portfolio Table 58. MedGenome Recent Development Table 59. Myriad Genetics Company Information Table 60. Myriad Genetics Business Overview Table 61. Myriad Genetics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Myriad Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 63. Myriad Genetics Recent Development Table 64. Roche Company Information Table 65. Roche Business Overview Table 66. Roche Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Roche Genetic Screening for Carrier Diseases Product Portfolio Table 68. Roche Recent Development Table 69. Natera Company Information Table 70. Natera Business Overview Table 71. Natera Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Natera Genetic Screening for Carrier Diseases Product Portfolio Table 73. Natera Recent Development Table 74. OPKO Health Company Information Table 75. OPKO Health Business Overview Table 76. OPKO Health Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. OPKO Health Genetic Screening for Carrier Diseases Product Portfolio Table 78. OPKO Health Recent Development Table 79. 23andMe Company Information Table 80. 23andMe Business Overview Table 81. 23andMe Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. 23andMe Genetic Screening for Carrier Diseases Product Portfolio Table 83. 23andMe Recent Development Table 84. bioMérieux Company Information Table 85. bioMérieux Business Overview Table 86. bioMérieux Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. bioMérieux Genetic Screening for Carrier Diseases Product Portfolio Table 88. bioMérieux Recent Development Table 89. EKF Diagnostics Company Information Table 90. EKF Diagnostics Business Overview Table 91. EKF Diagnostics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 92. EKF Diagnostics Genetic Screening for Carrier Diseases Product Portfolio Table 93. EKF Diagnostics Recent Development Table 94. Gene by Gene (myDNA) Company Information Table 95. Gene by Gene (myDNA) Business Overview Table 96. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 97. Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Portfolio Table 98. Gene by Gene (myDNA) Recent Development Table 99. Fulgent Genetics Company Information Table 100. Fulgent Genetics Business Overview Table 101. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 102. Fulgent Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 103. Fulgent Genetics Recent Development Table 104. NxGen MDx Company Information Table 105. NxGen MDx Business Overview Table 106. NxGen MDx Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 107. NxGen MDx Genetic Screening for Carrier Diseases Product Portfolio Table 108. NxGen MDx Recent Development Table 109. Sonic Genetics Company Information Table 110. Sonic Genetics Business Overview Table 111. Sonic Genetics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 112. Sonic Genetics Genetic Screening for Carrier Diseases Product Portfolio Table 113. Sonic Genetics Recent Development Table 114. My Baby Company Information Table 115. My Baby Business Overview Table 116. My Baby Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 117. My Baby Genetic Screening for Carrier Diseases Product Portfolio Table 118. My Baby Recent Development Table 119. AncestryDNA Company Information Table 120. AncestryDNA Business Overview Table 121. AncestryDNA Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 122. AncestryDNA Genetic Screening for Carrier Diseases Product Portfolio Table 123. AncestryDNA Recent Development Table 124. DiaSorin Company Information Table 125. DiaSorin Business Overview Table 126. DiaSorin Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 127. DiaSorin Genetic Screening for Carrier Diseases Product Portfolio Table 128. DiaSorin Recent Development Table 129. Grifols Company Information Table 130. Grifols Business Overview Table 131. Grifols Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 132. Grifols Genetic Screening for Carrier Diseases Product Portfolio Table 133. Grifols Recent Development Table 134. BGI Genomics Company Information Table 135. BGI Genomics Business Overview Table 136. BGI Genomics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 137. BGI Genomics Genetic Screening for Carrier Diseases Product Portfolio Table 138. BGI Genomics Recent Development Table 139. Chigene Company Information Table 140. Chigene Business Overview Table 141. Chigene Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 142. Chigene Genetic Screening for Carrier Diseases Product Portfolio Table 143. Chigene Recent Development Table 144. Jiajian Medical Testing Company Information Table 145. Jiajian Medical Testing Business Overview Table 146. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 147. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Portfolio Table 148. Jiajian Medical Testing Recent Development Table 149. Genesky Company Information Table 150. Genesky Business Overview Table 151. Genesky Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 152. Genesky Genetic Screening for Carrier Diseases Product Portfolio Table 153. Genesky Recent Development Table 154. Berry Genomics Company Information Table 155. Berry Genomics Business Overview Table 156. Berry Genomics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 157. Berry Genomics Genetic Screening for Carrier Diseases Product Portfolio Table 158. Berry Genomics Recent Development Table 159. Weihansi Biomedical Technology Company Information Table 160. Weihansi Biomedical Technology Business Overview Table 161. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 162. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Portfolio Table 163. Weihansi Biomedical Technology Recent Development Table 164. Annaroad Company Information Table 165. Annaroad Business Overview Table 166. Annaroad Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026) Table 167. Annaroad Genetic Screening for Carrier Diseases Product Portfolio Table 168. Annaroad Recent Development Table 169. North America Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 170. North America Genetic Screening for Carrier Diseases Market Size by Type (2027-2032) & (US$ Million) Table 171. North America Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 172. North America Genetic Screening for Carrier Diseases Market Size by Application (2027-2032) & (US$ Million) Table 173. North America Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. North America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) Table 175. North America Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) Table 176. Europe Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 177. Europe Genetic Screening for Carrier Diseases Market Size by Type (2027-2032) & (US$ Million) Table 178. Europe Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 179. Europe Genetic Screening for Carrier Diseases Market Size by Application (2027-2032) & (US$ Million) Table 180. Europe Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 181. Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) Table 182. Europe Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) Table 183. China Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 184. China Genetic Screening for Carrier Diseases Market Size by Type (2027-2032) & (US$ Million) Table 185. China Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 186. China Genetic Screening for Carrier Diseases Market Size by Application (2027-2032) & (US$ Million) Table 187. Asia Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 188. Asia Genetic Screening for Carrier Diseases Market Size by Type (2027-2032) & (US$ Million) Table 189. Asia Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 190. Asia Genetic Screening for Carrier Diseases Market Size by Application (2027-2032) & (US$ Million) Table 191. Asia Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 192. Asia Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) Table 193. Asia Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) Table 194. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2021-2026) & (US$ Million) Table 195. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2027-2032) & (US$ Million) Table 196. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2021-2026) & (US$ Million) Table 197. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2027-2032) & (US$ Million) Table 198. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021-2026) Table 200. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2027-2032) Table 201. Research Programs/Design for This Report Table 202. Authors List of This Report Table 203. Secondary Sources Table 204. Primary Sources List of Figures Figure 1. Genetic Screening for Carrier Diseases Product Image Figure 2. Global Genetic Screening for Carrier Diseases Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Genetic Screening for Carrier Diseases Market Share by Type: 2025 VS 2032 Figure 4. NGS Image Figure 5. Whole Exome Sequencing Image Figure 6. Others Image Figure 7. Global Genetic Screening for Carrier Diseases Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Genetic Screening for Carrier Diseases Market Share by Application: 2025 VS 2032 Figure 9. Couple Image Figure 10. Individual Image Figure 11. Global Genetic Screening for Carrier Diseases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 13. Global Genetic Screening for Carrier Diseases Market Share by Region: 2025 VS 2032 Figure 14. Years Considered Figure 15. Global Genetic Screening for Carrier Diseases Market Share by Players in 2025 Figure 16. Global Top 5 and 10 Genetic Screening for Carrier Diseases Players Market Share by Revenue in 2025 Figure 17. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Genetic Screening for Carrier Diseases Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Genetic Screening for Carrier Diseases Revenue Market Share by Type (2021-2032) Figure 20. Global Genetic Screening for Carrier Diseases Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Genetic Screening for Carrier Diseases Revenue Market Share by Application (2021-2032) Figure 22. North America Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 23. North America Genetic Screening for Carrier Diseases Market Share by Type (2021-2032) Figure 24. North America Genetic Screening for Carrier Diseases Market Share by Application (2021-2032) Figure 25. North America Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 26. United States Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 27. Canada Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 28. Mexico Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 29. Europe Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 30. Europe Genetic Screening for Carrier Diseases Market Share by Type (2021-2032) Figure 31. Europe Genetic Screening for Carrier Diseases Market Share by Application (2021-2032) Figure 32. Europe Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 33. Germany Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 34. France Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 35. U.K. Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 36. Italy Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 37. Russia Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 38. Nordic Countries Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 39. China Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 40. China Genetic Screening for Carrier Diseases Market Share by Type (2021-2032) Figure 41. China Genetic Screening for Carrier Diseases Market Share by Application (2021-2032) Figure 42. Asia Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 43. Asia Genetic Screening for Carrier Diseases Market Share by Type (2021-2032) Figure 44. Asia Genetic Screening for Carrier Diseases Market Share by Application (2021-2032) Figure 45. Asia Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 46. Japan Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 47. South Korea Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 48. Taiwan Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 49. Southeast Asia Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 50. India Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 51. Australia Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Type (2021-2032) Figure 54. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Application (2021-2032) Figure 55. South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Country (2021-2032) Figure 56. Brazil Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 57. South Africa Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 58. Saudi Arabia Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 59. Turkey Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 60. Argentina Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 61. UAE Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 62. Egypt Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 63. Chile Genetic Screening for Carrier Diseases Market Size (2021-2032) & (US$ Million) Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • NGS
  • Whole Exome Sequencing
  • Others
Applications
  • Couple
  • Individual
Companies covered
  • Thermo Fisher Scientific
  • Eurofins Scientific
  • Illumina
  • Invitae
  • MedGenome
  • Myriad Genetics
  • Roche
  • Natera
  • OPKO Health
  • 23andMe
  • bioMérieux
  • EKF Diagnostics
  • Gene by Gene (myDNA)
  • Fulgent Genetics
  • NxGen MDx
  • Sonic Genetics
  • My Baby
  • AncestryDNA
  • DiaSorin
  • Grifols
  • BGI Genomics
  • Chigene
  • Jiajian Medical Testing
  • Genesky
  • Berry Genomics
  • Weihansi Biomedical Technology
  • Annaroad

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Genetic Screening for Carrier Diseases Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 NGS
  5. 1.2.3 Whole Exome Sequencing
  6. 1.2.4 Others
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Genetic Screening for Carrier Diseases Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Couple
  10. 1.3.3 Individual
  11. 1.4 Global Market Growth Prospects
  12. 1.5 Global Genetic Screening for Carrier Diseases Growth Trends by Region
  13. 1.5.1 Global Genetic Screening for Carrier Diseases Market Size by Region: 2021 VS 2025 VS 2032
  14. 1.5.2 Genetic Screening for Carrier Diseases Market Size by Region (2021-2026)
  15. 1.5.3 Genetic Screening for Carrier Diseases Market Size by Region (2027-2032)
  16. 1.6 Assumptions and Limitations
  17. 1.7 Study Goals and Objectives
  18. 1.8 Years Considered
2 Global Genetic Screening for Carrier Diseases Market Dynamics
  1. 2.1 Genetic Screening for Carrier Diseases Industry Trends
  2. 2.2 Genetic Screening for Carrier Diseases Industry Drivers
  3. 2.3 Genetic Screening for Carrier Diseases Industry Opportunities and Challenges
  4. 2.4 Genetic Screening for Carrier Diseases Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Genetic Screening for Carrier Diseases Revenue by Company (2021-2026)
  2. 3.2 Global Genetic Screening for Carrier Diseases Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Genetic Screening for Carrier Diseases Key Company Head office and Area Served
  4. 3.4 Global Genetic Screening for Carrier Diseases Company, Product Type & Application
  5. 3.5 Global Genetic Screening for Carrier Diseases Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Genetic Screening for Carrier Diseases Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Genetic Screening for Carrier Diseases Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Genetic Screening for Carrier Diseases Tier 1, Tier 2, and Tier 3
4 Genetic Screening for Carrier Diseases Market by Type
  1. 4.1 Global Genetic Screening for Carrier Diseases Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Genetic Screening for Carrier Diseases Market Size by Type (2021-2032)
  3. 4.3 Global Genetic Screening for Carrier Diseases Market Size Share by Type (2021-2032)
5 Genetic Screening for Carrier Diseases Market by Application
  1. 5.1 Global Genetic Screening for Carrier Diseases Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Genetic Screening for Carrier Diseases Market Size by Application (2021-2032)
  3. 5.3 Global Genetic Screening for Carrier Diseases Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Thermo Fisher Scientific
  2. 6.1.1 Thermo Fisher Scientific Company Information
  3. 6.1.2 Thermo Fisher Scientific Business Overview
  4. 6.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product Portfolio
  6. 6.1.5 Thermo Fisher Scientific Recent Developments
  7. 6.2 Eurofins Scientific
  8. 6.2.1 Eurofins Scientific Company Information
  9. 6.2.2 Eurofins Scientific Business Overview
  10. 6.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Product Portfolio
  12. 6.2.5 Eurofins Scientific Recent Developments
  13. 6.3 Illumina
  14. 6.3.1 Illumina Company Information
  15. 6.3.2 Illumina Business Overview
  16. 6.3.3 Illumina Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Illumina Genetic Screening for Carrier Diseases Product Portfolio
  18. 6.3.5 Illumina Recent Developments
  19. 6.4 Invitae
  20. 6.4.1 Invitae Company Information
  21. 6.4.2 Invitae Business Overview
  22. 6.4.3 Invitae Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Invitae Genetic Screening for Carrier Diseases Product Portfolio
  24. 6.4.5 Invitae Recent Developments
  25. 6.5 MedGenome
  26. 6.5.1 MedGenome Company Information
  27. 6.5.2 MedGenome Business Overview
  28. 6.5.3 MedGenome Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 MedGenome Genetic Screening for Carrier Diseases Product Portfolio
  30. 6.5.5 MedGenome Recent Developments
  31. 6.6 Myriad Genetics
  32. 6.6.1 Myriad Genetics Company Information
  33. 6.6.2 Myriad Genetics Business Overview
  34. 6.6.3 Myriad Genetics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Myriad Genetics Genetic Screening for Carrier Diseases Product Portfolio
  36. 6.6.5 Myriad Genetics Recent Developments
  37. 6.7 Roche
  38. 6.7.1 Roche Company Information
  39. 6.7.2 Roche Business Overview
  40. 6.7.3 Roche Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Roche Genetic Screening for Carrier Diseases Product Portfolio
  42. 6.7.5 Roche Recent Developments
  43. 6.8 Natera
  44. 6.8.1 Natera Company Information
  45. 6.8.2 Natera Business Overview
  46. 6.8.3 Natera Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Natera Genetic Screening for Carrier Diseases Product Portfolio
  48. 6.8.5 Natera Recent Developments
  49. 6.9 OPKO Health
  50. 6.9.1 OPKO Health Company Information
  51. 6.9.2 OPKO Health Business Overview
  52. 6.9.3 OPKO Health Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 OPKO Health Genetic Screening for Carrier Diseases Product Portfolio
  54. 6.9.5 OPKO Health Recent Developments
  55. 6.10 23andMe
  56. 6.10.1 23andMe Company Information
  57. 6.10.2 23andMe Business Overview
  58. 6.10.3 23andMe Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 23andMe Genetic Screening for Carrier Diseases Product Portfolio
  60. 6.10.5 23andMe Recent Developments
  61. 6.11 bioMérieux
  62. 6.11.1 bioMérieux Company Information
  63. 6.11.2 bioMérieux Business Overview
  64. 6.11.3 bioMérieux Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 bioMérieux Genetic Screening for Carrier Diseases Product Portfolio
  66. 6.11.5 bioMérieux Recent Developments
  67. 6.12 EKF Diagnostics
  68. 6.12.1 EKF Diagnostics Company Information
  69. 6.12.2 EKF Diagnostics Business Overview
  70. 6.12.3 EKF Diagnostics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 EKF Diagnostics Genetic Screening for Carrier Diseases Product Portfolio
  72. 6.12.5 EKF Diagnostics Recent Developments
  73. 6.13 Gene by Gene (myDNA)
  74. 6.13.1 Gene by Gene (myDNA) Company Information
  75. 6.13.2 Gene by Gene (myDNA) Business Overview
  76. 6.13.3 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Gene by Gene (myDNA) Genetic Screening for Carrier Diseases Product Portfolio
  78. 6.13.5 Gene by Gene (myDNA) Recent Developments
  79. 6.14 Fulgent Genetics
  80. 6.14.1 Fulgent Genetics Company Information
  81. 6.14.2 Fulgent Genetics Business Overview
  82. 6.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Product Portfolio
  84. 6.14.5 Fulgent Genetics Recent Developments
  85. 6.15 NxGen MDx
  86. 6.15.1 NxGen MDx Company Information
  87. 6.15.2 NxGen MDx Business Overview
  88. 6.15.3 NxGen MDx Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 NxGen MDx Genetic Screening for Carrier Diseases Product Portfolio
  90. 6.15.5 NxGen MDx Recent Developments
  91. 6.16 Sonic Genetics
  92. 6.16.1 Sonic Genetics Company Information
  93. 6.16.2 Sonic Genetics Business Overview
  94. 6.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Product Portfolio
  96. 6.16.5 Sonic Genetics Recent Developments
  97. 6.17 My Baby
  98. 6.17.1 My Baby Company Information
  99. 6.17.2 My Baby Business Overview
  100. 6.17.3 My Baby Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 My Baby Genetic Screening for Carrier Diseases Product Portfolio
  102. 6.17.5 My Baby Recent Developments
  103. 6.18 AncestryDNA
  104. 6.18.1 AncestryDNA Company Information
  105. 6.18.2 AncestryDNA Business Overview
  106. 6.18.3 AncestryDNA Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 AncestryDNA Genetic Screening for Carrier Diseases Product Portfolio
  108. 6.18.5 AncestryDNA Recent Developments
  109. 6.19 DiaSorin
  110. 6.19.1 DiaSorin Company Information
  111. 6.19.2 DiaSorin Business Overview
  112. 6.19.3 DiaSorin Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 DiaSorin Genetic Screening for Carrier Diseases Product Portfolio
  114. 6.19.5 DiaSorin Recent Developments
  115. 6.20 Grifols
  116. 6.20.1 Grifols Company Information
  117. 6.20.2 Grifols Business Overview
  118. 6.20.3 Grifols Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 Grifols Genetic Screening for Carrier Diseases Product Portfolio
  120. 6.20.5 Grifols Recent Developments
  121. 6.21 BGI Genomics
  122. 6.21.1 BGI Genomics Company Information
  123. 6.21.2 BGI Genomics Business Overview
  124. 6.21.3 BGI Genomics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 BGI Genomics Genetic Screening for Carrier Diseases Product Portfolio
  126. 6.21.5 BGI Genomics Recent Developments
  127. 6.22 Chigene
  128. 6.22.1 Chigene Company Information
  129. 6.22.2 Chigene Business Overview
  130. 6.22.3 Chigene Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  131. 6.22.4 Chigene Genetic Screening for Carrier Diseases Product Portfolio
  132. 6.22.5 Chigene Recent Developments
  133. 6.23 Jiajian Medical Testing
  134. 6.23.1 Jiajian Medical Testing Company Information
  135. 6.23.2 Jiajian Medical Testing Business Overview
  136. 6.23.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  137. 6.23.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product Portfolio
  138. 6.23.5 Jiajian Medical Testing Recent Developments
  139. 6.24 Genesky
  140. 6.24.1 Genesky Company Information
  141. 6.24.2 Genesky Business Overview
  142. 6.24.3 Genesky Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  143. 6.24.4 Genesky Genetic Screening for Carrier Diseases Product Portfolio
  144. 6.24.5 Genesky Recent Developments
  145. 6.25 Berry Genomics
  146. 6.25.1 Berry Genomics Company Information
  147. 6.25.2 Berry Genomics Business Overview
  148. 6.25.3 Berry Genomics Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  149. 6.25.4 Berry Genomics Genetic Screening for Carrier Diseases Product Portfolio
  150. 6.25.5 Berry Genomics Recent Developments
  151. 6.26 Weihansi Biomedical Technology
  152. 6.26.1 Weihansi Biomedical Technology Company Information
  153. 6.26.2 Weihansi Biomedical Technology Business Overview
  154. 6.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  155. 6.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product Portfolio
  156. 6.26.5 Weihansi Biomedical Technology Recent Developments
  157. 6.27 Annaroad
  158. 6.27.1 Annaroad Company Information
  159. 6.27.2 Annaroad Business Overview
  160. 6.27.3 Annaroad Genetic Screening for Carrier Diseases Revenue and Gross Margin (US$ Million) & (2021-2026)
  161. 6.27.4 Annaroad Genetic Screening for Carrier Diseases Product Portfolio
  162. 6.27.5 Annaroad Recent Developments
7 North America
  1. 7.1 North America Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 7.2 North America Genetic Screening for Carrier Diseases Market Size by Type
  3. 7.2.1 North America Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
  4. 7.2.2 North America Genetic Screening for Carrier Diseases Market Size by Type (2027-2032)
  5. 7.2.3 North America Genetic Screening for Carrier Diseases Market Share by Type (2021-2032)
  6. 7.3 North America Genetic Screening for Carrier Diseases Market Size by Application
  7. 7.3.1 North America Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
  8. 7.3.2 North America Genetic Screening for Carrier Diseases Market Size by Application (2027-2032)
  9. 7.3.3 North America Genetic Screening for Carrier Diseases Market Share by Application (2021-2032)
  10. 7.4 North America Genetic Screening for Carrier Diseases Market Size by Country
  11. 7.4.1 North America Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  13. 7.4.3 North America Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  14. 7.4.4 North America Genetic Screening for Carrier Diseases Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 8.2 Europe Genetic Screening for Carrier Diseases Market Size by Type
  3. 8.2.1 Europe Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
  4. 8.2.2 Europe Genetic Screening for Carrier Diseases Market Size by Type (2027-2032)
  5. 8.2.3 Europe Genetic Screening for Carrier Diseases Market Share by Type (2021-2032)
  6. 8.3 Europe Genetic Screening for Carrier Diseases Market Size by Application
  7. 8.3.1 Europe Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
  8. 8.3.2 Europe Genetic Screening for Carrier Diseases Market Size by Application (2027-2032)
  9. 8.3.3 Europe Genetic Screening for Carrier Diseases Market Share by Application (2021-2032)
  10. 8.4 Europe Genetic Screening for Carrier Diseases Market Size by Country
  11. 8.4.1 Europe Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  13. 8.4.3 Europe Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  14. 8.4.4 Europe Genetic Screening for Carrier Diseases Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 9.2 China Genetic Screening for Carrier Diseases Market Size by Type
  3. 9.2.1 China Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
  4. 9.2.2 China Genetic Screening for Carrier Diseases Market Size by Type (2027-2032)
  5. 9.2.3 China Genetic Screening for Carrier Diseases Market Share by Type (2021-2032)
  6. 9.3 China Genetic Screening for Carrier Diseases Market Size by Application
  7. 9.3.1 China Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
  8. 9.3.2 China Genetic Screening for Carrier Diseases Market Size by Application (2027-2032)
  9. 9.3.3 China Genetic Screening for Carrier Diseases Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 10.2 Asia Genetic Screening for Carrier Diseases Market Size by Type
  3. 10.2.1 Asia Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
  4. 10.2.2 Asia Genetic Screening for Carrier Diseases Market Size by Type (2027-2032)
  5. 10.2.3 Asia Genetic Screening for Carrier Diseases Market Share by Type (2021-2032)
  6. 10.3 Asia Genetic Screening for Carrier Diseases Market Size by Application
  7. 10.3.1 Asia Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
  8. 10.3.2 Asia Genetic Screening for Carrier Diseases Market Size by Application (2027-2032)
  9. 10.3.3 Asia Genetic Screening for Carrier Diseases Market Share by Application (2021-2032)
  10. 10.4 Asia Genetic Screening for Carrier Diseases Market Size by Country
  11. 10.4.1 Asia Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  13. 10.4.3 Asia Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  14. 10.4.4 Asia Genetic Screening for Carrier Diseases Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Genetic Screening for Carrier Diseases Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst